Literature DB >> 361136

Recirculation of prostacyclin (PGI2) in the dog.

G J Dusting, S Moncada, J R Vane.   

Abstract

1 The inactivation of prostacyclin (PGI2) in the circulation of anaesthetized dogs has been studied by the blood-bathed organ bioassay technique. 2 Spiral strips of bovine coronary and rabbit coeliac or mesenteric artery detected concentrations of PGI2 of 2 to 5 ng/ml. These tissues were insensitive to concentrations at least 200 fold higher of 15-oxo-PGI2 and 6-oxo-PGF1alpha. 3 PGI2 assayed on bovine coronary artery, rabbit coeliac artery or rat stomach strip, had a half life in blood of 3.0 +/- 0.3 min, indicating non-enzymatic degradation. 4 No disappearance could be detected by bovine coronary artery when PGI2 was infused across the lungs (0.1 to 0.5 microgram kg-1 min-1). However, PGI2 was partially inactivated in passage through vascular beds of hindquarters and liver. 5 Of PGI2 infused into the aorta 35 to 65% escaped inactivation in one complete circulation. Therefore, endogenous PGI2 released from the lungs may function as a circulating hormone.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 361136      PMCID: PMC1668311          DOI: 10.1111/j.1476-5381.1978.tb17307.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1964-10

2.  Synthesis and sterochemistry of prostacyclin and synthesis of 6-ketoprostagliandin F1alpha.

Authors:  R A Johnson; F H Lincoln; J L Thompson; E G Nidy; S A Mizak; U Axen
Journal:  J Am Chem Soc       Date:  1977-06-08       Impact factor: 15.419

3.  Chemical stability of prostacyclin (PGI2) in aqueous solutions.

Authors:  M J Cho; M A Allen
Journal:  Prostaglandins       Date:  1978-06

4.  Generation of prostacyclin by lungs in vivo and its release into the arterial circulation.

Authors:  R J Gryglewski; R Korbut; A Ocetkiewicz
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

5.  Prostacyclin is a circulating hormone.

Authors:  S Moncada; R Korbut; S Bunting; J R Vane
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

6.  Cardiovascular actions of prostacyclin (PCI2) in chloralose anaesthetized dogs [proceedings].

Authors:  J M Armstrong; D Chapple; G J Dusting; R Hughes; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739

7.  Vascular actions of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog.

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Eur J Pharmacol       Date:  1978-05-01       Impact factor: 4.432

8.  Disappearance of prostacyclin (PGI2) in the circulation of the dog [proceedings].

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

9.  The differential response of a novel bioassay tissue, the rabbit transverse stomach-strip, to prostacyclin (PGI2) and other prostaglandins [proceedings].

Authors:  S Moncada; K G Mugridge; B J Whittle
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

10.  Comparison of the vasodepressor effects of prostacyclin and 6-oxo-prostaglandin F1alpha with those of prostaglandin E2 in rats and rabbits.

Authors:  J M Armstrong; N Lattimer; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1978-01       Impact factor: 8.739

View more
  20 in total

Review 1.  Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells.

Authors:  P N Belloni; R J Tressler
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

Review 2.  Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins.

Authors:  Takeo Nakanishi; Ikumi Tamai
Journal:  AAPS J       Date:  2017-12-04       Impact factor: 4.009

3.  Increased levels of prostaglandin-like material in the canine blood during arterial hypotension produced by hydralazine, dihydralazine and minoxidil.

Authors:  G Haeusler; M Gerold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

Review 4.  Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

Review 5.  Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Postgrad Med J       Date:  1983-12       Impact factor: 2.401

Review 6.  The biochemical properties of the pulmonary circulation.

Authors:  J A Pang; D M Geddes
Journal:  Lung       Date:  1981       Impact factor: 2.584

7.  Inhibitors of prostaglandin dehydrogenase (Ph CL 28A and Ph CK 61A) increase output of prostaglandins from rat isolated lung.

Authors:  Y S Bakhle; J J Pankhania
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

8.  Prostacyclin can either increase or decrease heart rate depending on the basal state.

Authors:  M Chiavarelli; S Moncada; K M Mullane
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

9.  Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis.

Authors:  M P Fink; T J MacVittie; L C Casey
Journal:  Ann Surg       Date:  1984-11       Impact factor: 12.969

10.  [Aerosolized and intravenous prostacyclin during one-lung ventilation. Hemodynamic and pulmonary effects].

Authors:  M Bund; D Henzler; R Walz; R Rossaint; S Piepenbrock; R Kuhlen
Journal:  Anaesthesist       Date:  2004-07       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.